Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
305
NCT04250922
LAM561 With RT and TMZ for Adults With Glioblastoma
Phase: Phase 2/3
Role: Collaborator
Start: Dec 1, 2019
Completion: May 30, 2025
NCT06450990
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 8, 2024
Completion: Feb 26, 2026